United States Second Circuit

Judgment dismissing amended complaint alleging defendants issued a misleading press release describing the preliminary clinical trial results for Alzheimer drug is affirmed, where: 1) nothing omitted from the press release rendered it false or misleading to a reasonable investor; and 2) plaintiff offered insufficient additional allegations to cure this deficiency.

Appellate Information

• Decided 02/01/2013
• Published 02/01/2013

Judges

• HALL

Court

• United States Second Circuit

Counsel